NeoLAB® Solid Tumor Liquid Biopsy Benefits
Pan-cancer tumor types (bladder, brain/CNS, breast, cervical, colorectal, stomach, head and neck, etc.)
Detects 900+ hotspot SNVs and indels across 44 genes
Accurate results are returned within 7 calendar days after sample is received
- 98% accuracy, 95.1% sensitivity, 98.8% specificity
- Limit of Detection: 0.1% allele fraction for indels; 0.15% for SNV
NeoLAB® Heme Liquid Biopsy Benefits
Sensitive assessment of therapy effectiveness and disease progression
Allows more frequent monitoring due to non-invasive collection method
Plasma provides a homogeneous sample and removes the potential for missing patchy disease with marrow collection
Spares the patients an invasive, uncomfortable, and expensive procedure
See complete test details for NeoLAB® Solid Tumor and Heme Liquid Biopsy.
Get a printable test description and specimen requirements.
NeoGenomics is proud to offer in-home specimen collection for liquid biopsy assays through our national mobile phlebotomy program, providing safe and convenient blood draws for liquid biopsy with no added costs for patients.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients